» Articles » PMID: 30677091

The Human Cytomegalovirus UL38 Protein Drives MTOR-independent Metabolic Flux Reprogramming by Inhibiting TSC2

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2019 Jan 25
PMID 30677091
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Human Cytomegalovirus (HCMV) infection induces several metabolic activities that are essential for viral replication. Despite the important role that this metabolic modulation plays during infection, the viral mechanisms involved are largely unclear. We find that the HCMV UL38 protein is responsible for many aspects of HCMV-mediated metabolic activation, with UL38 being necessary and sufficient to drive glycolytic activation and induce the catabolism of specific amino acids. UL38's metabolic reprogramming role is dependent on its interaction with TSC2, a tumor suppressor that inhibits mTOR signaling. Further, shRNA-mediated knockdown of TSC2 recapitulates the metabolic phenotypes associated with UL38 expression. Notably, we find that in many cases the metabolic flux activation associated with UL38 expression is largely independent of mTOR activity, as broad spectrum mTOR inhibition does not impact UL38-mediated induction of glycolysis, glutamine consumption, or the secretion of proline or alanine. In contrast, the induction of metabolite concentrations observed with UL38 expression are largely dependent on active mTOR. Collectively, our results indicate that the HCMV UL38 protein induces a pro-viral metabolic environment via inhibition of TSC2.

Citing Articles

Infection-induced lysine lactylation enables herpesvirus immune evasion.

Tyl M, Merengwa V, Cristea I Sci Adv. 2025; 11(2):eads6215.

PMID: 39772686 PMC: 11708889. DOI: 10.1126/sciadv.ads6215.


Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized mice.

Diggins N, Pham A, Mitchell J, Parkins C, Slind L, Turner R PLoS Pathog. 2024; 20(12):e1012285.

PMID: 39661658 PMC: 11666035. DOI: 10.1371/journal.ppat.1012285.


Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches.

Mokry R, Purdy J Proc Natl Acad Sci U S A. 2024; 121(48):e2412966121.

PMID: 39560652 PMC: 11621781. DOI: 10.1073/pnas.2412966121.


Clinical implications of cytomegalovirus in glioblastoma progression and therapy.

Mercado N, Real J, Kaiserman J, Panagioti E, Cook C, Lawler S NPJ Precis Oncol. 2024; 8(1):213.

PMID: 39343770 PMC: 11439950. DOI: 10.1038/s41698-024-00709-4.


A UL26-PIAS1 complex antagonizes anti-viral gene expression during Human Cytomegalovirus infection.

Ciesla J, Huang K, Wagner E, Munger J PLoS Pathog. 2024; 20(5):e1012058.

PMID: 38768227 PMC: 11142722. DOI: 10.1371/journal.ppat.1012058.


References
1.
Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

2.
McKinney C, Zavadil J, Bianco C, Shiflett L, Brown S, Mohr I . Global reprogramming of the cellular translational landscape facilitates cytomegalovirus replication. Cell Rep. 2013; 6(1):9-17. PMC: 3975909. DOI: 10.1016/j.celrep.2013.11.045. View

3.
Ben-Sahra I, Howell J, Asara J, Manning B . Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013; 339(6125):1323-8. PMC: 3753690. DOI: 10.1126/science.1228792. View

4.
Benjamin D, Colombi M, Moroni C, Hall M . Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011; 10(11):868-80. DOI: 10.1038/nrd3531. View

5.
Cunningham J, Moreno M, Lodi A, Ronen S, Ruggero D . Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell. 2014; 157(5):1088-103. PMC: 4140650. DOI: 10.1016/j.cell.2014.03.052. View